References - Public Safety Medicine

Coronary Artery Disease

sec_arr References
SECTIONS

References 

  1. Varvarigou V, Farioli A, Korre M, Sato S, Dahabreh IJ, Kales SN. Law enforcement duties and sudden cardiac death among police officers in United States: case distribution study. BMJ. 2014;349:g6534.
  2. Zimmerman FH. Cardiovascular disease and risk factors in law enforcement personnel: a comprehensive review. Cardiol Rev. 2012;20:159–166.
  3. Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128:873–934.
  4. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810–1852.
  5. Commission on Peace Officer Standards and Training (POST). Medical Screening Manual. State of California; Revised May 2014:9–11.
  6. Thompson PD, Myerburg RJ, Levine BD, Udelson JE, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66:2406–2411.
  7. NFPA. 1582 Standard on Comprehensive Occupational Medical Program for Fire Departments. Quincy, MA: National Fire Protection Association (NFPA); 2013.
  8. Takagi Y, Yasuda S, Tsunoda R, et al. Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association. Circ Arrhythm Electrophysiol. 2011;4:295–302.
  9. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U. High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol. 2012;59:655–662.
  10. Baggish AL, Thompson PD. The Athlete’s Heart 2007: diseases of the coronary circulation. Cardiol Clin. 2007;25:431–440, vi.
  11. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379–1385.
  12. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr. 1997;131:888–893.
  13. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927–e999.
  14. N.A. Cardiovascular Evaluation of Army Civilian Police and Sercurity Guards. In: Army MC-Dot, ed.; 2018.
  15. ECRI USDoT, Federal Motor Carrier Safety Administration, MANILA Consulting Group, Inc. FMCSA Evidence Report: Cardiovascular Disease and Commercial Motor Vehicle Driver Safety (Expedited Review). 2007.
  16. D’Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139:272–281.